SCHEMBL23211673

SCHEMBL23211673

C#Cc1ccc(CN(CCOC(=O)OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)CC2CCCCN2C(=O)OC(C)(C)C23CC4CC(CC(C4)C2)C3)cc1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.35
▸ TOP2A P11388 1/20 0.35
▸ TK1 P04183 2/20 0.34
▸ BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23225370 0.90 TOP2A (0.34) TOP2ATK1
SCHEMBL23225379 0.85 RNASE1 (0.37) TOP2ATK1
SCHEMBL23211666 0.81 RNASE1 (0.41) TOP2ATK1
SCHEMBL21216117 0.78 RNASE1 (0.43) TOP2ATK1
SCHEMBL21216255 0.78 RNASE1 (0.43) TOP2ATK1
SCHEMBL30932968 0.78 RNASE1 (0.43) TOP2ATK1
SCHEMBL30932972 0.78 RNASE1 (0.38) TOP2ATK1
SCHEMBL20535582 0.78 — —
SCHEMBL20535903 0.77 KDM1A (0.34) —
SCHEMBL23965518 0.76 POLB (0.40) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161869-B2 Thermally-cleavable protecting and linker groups EVONETIX LTD. (GB) 2021-11-02 — — US disclosed
US-20210107934-A1 THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS SILICON VALLEY BANK 2021-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107934-A1 THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS CTDSP1, RNGTT, SSU72 POLB 24/4885TOP2A 96/4885TK1 152/4885
US-11161869-B2 Thermally-cleavable protecting and linker groups CTDSP1, RNGTT, SSU72 POLB 24/4885TOP2A 96/4885TK1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback